Down to Coverage

While many US insurance companies will pay for BRCA 1 or BRCA 2 testing in a patient with a family history of breast or ovarian cancer, NPR's Shots blog reports that insurers often "balk at providing coverage" for tests examining other mutations linked to breast or ovarian cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

An Australian study of personalized medicine has run into problems as it recruits patients.